The latest report from the Childhood Cancer Survivor Study highlights the effect of cancer therapy on endocrine abnormalities over >30 years of follow up. Overall, 44% of patients had one endocrine abnormality, 16.7% had two and 6.6% had three or more. The findings highlight the need for long-term endocrine monitoring of these patients.
Refers to Mostoufi-Moab, S. et al. Endocrine abnormalities in aging survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J. Clin. Oncol.http://dx.doi.org/10.1200/JCO.2016.66.6545 (2016).